Ken Kato
MD, PhD
Chief, Head and Neck/Esophageal Oncology
👥Biography 个人简介
Ken Kato has been a principal investigator on KEYNOTE-590 establishing pembrolizumab plus chemotherapy for first-line esophageal cancer including ESCC. His clinical research at Japan's National Cancer Center has advanced immunotherapy for esophageal squamous cell carcinoma. He leads multiple ongoing first-line combination trials.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Ken Kato 的研究动态
Follow Ken Kato's research updates
留下邮箱，当我们发布与 Ken Kato（National Cancer Center Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment